A new pan-industry group, the first of its kind worldwide, has been formed to tackle the increasing threat that wormer resistance poses to horse health and the equine industry. Termed CANTER to communicate the urgency of its crusade, Controlling ANTiparasitic resistance in Equines Responsibly brings together voluntary representation from the widest reaches of the sector, including BEVA representatives. These include leading experts in the field across prescribers, diagnostic providers, pharmaceu

This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets. New marketing authorisations Table 1 shows the new marketing authorisations for January 2023 TABLE 1: New marketing authorisations in January 2023 See the VMD’s Product Information Database for more information on each of these products. This includes separate links for the authorisation territori

This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets. New marketing authorisations Table 1 shows the new marketing authorisations for November 2022. TABLE 1: New marketing authorisations in November 2022 New Marketing Authorisations Product name and target species Active substance Authorisation Holder, territory, and distribution category Therapeutic group